How Are Ozempic and Wegovy Similar
The latest GLP-1 weight loss drugs are generally approved for chronic weight management in adults with a BMI of 30 or higher and people with a BMI of 27 or higher who also have weight-related conditions like high blood pressure, type 2 diabetes, or high cholesterol
A predictive Random Forest model estimated drug-specific maximal BMI reduction as 8.5% for liraglutide, 14.2% for semaglutide, and 16.8% for tirzepatide across simulated genotype-response profiles
Semaglutide GLP-1, Mounjaro, Wegovy, and Ozempic have been shown to be effective in promoting weight loss in adults with obesity, but the long-term effects on weight maintenance are still being studied
Ozempic: 16% to 20% of users
Med spas not only provide medical supervision for weight loss but can also integrate treatments like skin tightening or body contouring